Sofosbuvir plus Ribavirin for the Treatment of Russian Patients with Chronic HCV Genotype 1 or 3 Infection

被引：0

作者：

Chulanov, Vladimir ^{[1
]}

Zhdanov, Konstantin ^{[2
]}

Kersey, Kathryn ^{[3
]}

Zhu, Yanni ^{[3
]}

Massetto, Benedetta ^{[3
]}

Zhuravel, Sergey ^{[4
]}

Romanova, Svetlana ^{[5
]}

Nurmukhametova, Elena ^{[6
]}

Morozov, Viacheslav ^{[7
]}

Kozhevnikova, Galina ^{[1
]}

Gogova, Larisa ^{[8
]}

Geyvandova, Natalia ^{[9
]}

Gankina, Natalia ^{[10
]}

Chesnokov, Evgenii ^{[11
]}

Burnevich, Eduard Z. ^{[12
]}

Bessonova, Elena ^{[13
]}

Abdurakhmanov, Djamal ^{[14
]}

Brainard, Diana M. ^{[3
]}

McHutchison, John G. ^{[3
]}

Bakulin, Igor G. ^{[15
]}

Isakov, Vasily ^{[16
]}

机构：

[1] Cent Res Inst Epidemiol, Moscow, Russia

[2] SM Kirov Mil Med Acad, St Petersburg, Russia

[3] Gilead Sci Inc, Foster City, CA 94404 USA

[4] Sci Res Inst Emergency Care, Moscow, Russia

[5] Ctr Prevent & Control AIDS & Infect Dis, St Petersburg, Russia

[6] Infect Clin Hosp 1, Moscow, Russia

[7] Med Co Hepatolog LLC, Samara, Russia

[8] Russian Acad Sci, Cent Clin Hosp, Moscow, Russia

[9] Stavropol Reg Clin Ctr Special Med Care, Stavropol, Russia

[10] Krasnoyarsk Reg Ctr Prevent & Control AIDS & Infe, Krasnoyarsk, Russia

[11] Consultat & Diagnost Ctr, Tyumen, Russia

[12] City Clin Hosp 24, Moscow, Russia

[13] Sverdlovsk Reg Clin Hosp 1, Ekaterinburg, Russia

[14] IM Sechenov First Moscow State Med Univ, Moscow, Russia

[15] Moscow Cent Sci Inst Gastroenterol, Moscow, Russia

[16] Russian Acad Med Sci, Inst Nutr, Moscow 109801, Russia

来源：

HEPATOLOGY | 2014年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

982

引用

页码：676A / 677A

页数：2

共 50 条

[41] Safety and efficacy of daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV genotype 3 infection: Interim results of a multicenter European compassionate use program
Welzel, Tania M.
Petersen, Joerg
Ferenci, Peter
Gschwantler, Michael
Herzer, Kerstin
Cornberg, Markus
Schott, Eckart
Berg, Thomas
Spengler, Ulrich
Weiland, Ola
van der Valk, Marc
Geier, Andreas
Rockstroh, Juergen K.
Peck-Radosavljevic, Markus
Zhao, Yue
Exposito, Maria Jesus Jimenez
Zeuzem, Stefan
HEPATOLOGY, 2015, 62 : 225A - 226A
[42] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
Seo, Kayo
Kim, Soo Ki
Kim, Soo Ryang
Ohtani, Aya
Kobayashi, Mana
Kato, Airi
Morimoto, Eri
Saijo, Yuka
Kim, Ke Ih
Imoto, Susumu
Kim, Chi Wan
Yano, Yoshihiko
Kudo, Masatoshi
Hayashi, Yoshitake
DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
[43] Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin
Kanda, Tatsuo
Nakamura, Masato
Yasui, Shin
Haga, Yuki
Tawada, Akinobu
Suzuki, Eiichiro
Ooka, Yoshihiko
Takahashi, Koji
Sasaki, Reina
Wu, Shuang
Nakamoto, Shingo
Arai, Makoto
Imazeki, Fumio
Yokosuka, Osamu
BIOLOGY-BASEL, 2017, 6 (02):
[44] Improvement in liver disease parameters following treatment with daclatasvir plus sofosbuvir and ribavirin in patients with chronic HCV infection and advanced cirrhosis
Fontana, Robert J.
Poordad, Fred
Schiff, Eugene R.
Vierling, John M.
Landis, Charles S.
Bhore, Rafia
Yin, Philip
Noviello, Stephanie
Swenson, Eugene S.
HEPATOLOGY, 2015, 62 : 558A - 559A
[45] DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 3 INFECTION: INTERIM ANALYSIS OF A FRENCH MULTICENTER COMPASSIONATE USE PROGRAM
Hezode, C.
De Ledinghen, V.
Fontaine, H.
Zoulim, F.
Lebray, P.
Boyer, N.
Larrey, D.
Silvain, C.
Botta-Fridlund, D.
Leroy, V.
Bourliere, M.
D'Alteroche, L.
Hubert-Fouchard, I.
Guyader, D.
Rosa, I.
Nguyen-Khac, E.
Di Martino, V.
Carrat, F.
Fedchuk, L.
Akremi, R.
Bennai, Y.
Bronowicki, J. -P.
JOURNAL OF HEPATOLOGY, 2015, 62 : S265 - S266
[46] Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: interim analysis of a French multicenter compassionate use program
Hezode, C.
De Ledinghen, V.
Fontaine, H.
Zoulim, F.
Lebray, P.
Boyer, N.
Dominique, L.
Silvain, C.
Botta-Fridlund, D.
Leroy, V.
Bourliere, M.
D'alteroche, L.
Hubert-Fouchard, I.
Guyader, D.
Rosa, I.
Nguyen-Khac, E.
Di Martino, V.
Carrat, F.
Fedchuk, L.
Akremi, R.
Bennai, Y.
Bronowicki, J.
JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 29 - 29
[47] Efficacy of Ledipasvir and Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection
Gane, Edward J.
Hyland, Robert H.
An, Di
Svarovskaia, Evguenia
Pang, Phillip S.
Brainard, Diana
Stedman, Catherine A.
GASTROENTEROLOGY, 2015, 149 (06) : 1454 - +
[48] TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 3 INFECTION WITH OR WITHOUT CIRRHOSIS WITH SOFOSBUVIR AND VELPATASVIR WITH OR WITHOUT RIBAVIRIN
Bherwani, Sonny
Saumya, A. S.
Vyas, Kaushal
Narang, Sushil
Pandav, Nilesh
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 140 - 140
[49] Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection
Saab, S.
Gordon, S. C.
Park, H.
Sulkowski, M.
Ahmed, A.
Younossi, Z.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) : 657 - 675
[50] Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infectionn
Huang, Rui
Rao, Huiying
Xie, Qing
Gao, Zhiliang
Li, Wu
Jiang, Deyuan
Mo, Hongmei
Massetto, Benedetta
Stamm, Luisa M.
Brainard, Diana M.
Wei, Lai
JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (07) : 1313 - 1318

← 1 2 3 4 5 →